KRAS and cancer: So, in cancer cells with mutated KRAS genes, the GTPase activity and GAPs’ responsiveness to K-RAS protein become impaired, allowing a swift exchange of guanosine diphosphate (GDP) for GTP and allowing K-RAS to remain active in cancer cells.